Citadel Advisors’s Lumexa Imaging Holdings LMRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.4M Buy
331,781
+277,402
+510% +$3.15M ﹤0.01% 5610
2026
Q2
$613K Sell
54,379
-602,206
-92% -$5.5M ﹤0.01% 9377
2026
Q1
$5.65M Sell
656,585
-193,415
-23% -$2.66M ﹤0.01% 4143
2025
Q4
$15.7M Buy
+850,000
New +$15.3M ﹤0.01% 2645

Other funds holding LMRI

Citadel Advisors's LMRI Position: Q3 2026 in Review

Citadel Advisors increased its Lumexa Imaging Holdings (LMRI) stake by 510% in Q3 2026, buying an estimated $3.15M and bringing the position to 331,781 shares worth $3.4M. The position accounts for ﹤0.01% of the portfolio, ranked #5610.

Citadel Advisors first reported a position in LMRI in Q4 2025 and has held it in 4 quarters since. The position peaked at $15.7M in Q4 2025. 110 funds tracked by Wall St. Rank hold LMRI as of Q3 2026.

  • Citadel Advisors held 331,781 shares of Lumexa Imaging Holdings worth $3.4M as of Q3 2026.
  • Citadel Advisors bought 277,402 Lumexa Imaging Holdings shares in Q3 2026, an estimated $3.15M.
  • Lumexa Imaging Holdings made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #5610 holding.
  • Citadel Advisors first reported a position in Lumexa Imaging Holdings in Q4 2025 and has held it in 4 quarters since.
  • Citadel Advisors's Lumexa Imaging Holdings position peaked at $15.7M in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Lumexa Imaging Holdings as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.